Summary. VO2 max — the maximum rate at which the body can absorb and use oxygen during intense exercise — is the single strongest predictor of all-cause mortality in adults, outperforming traditional risk factors such as hypertension, smoking, and diabetes in large cohort analyses.
In 2018, a landmark analysis in JAMA Network Open of more than 122,000 adults undergoing treadmill testing at the Cleveland Clinic found that cardiorespiratory fitness — the ability captured by VO2 max — was inversely associated with long-term mortality, with no observed upper limit of benefit.
The adjusted hazard ratio for all-cause mortality comparing the lowest-fit to elite-fit groups was higher than the hazard ratios typically reported for end-stage renal disease, smoking, or type 2 diabetes.
For executives who spend their professional lives making decisions based on data, this is a signal impossible to ignore.
VO2 max integrates the performance of the heart, lungs, vascular tree, skeletal muscle mitochondria, and peripheral oxygen extraction into a single number — expressed in milliliters of oxygen per kilogram of body weight per minute (mL/kg/min).
Unlike LDL cholesterol or blood pressure, which describe one slice of cardiovascular biology, VO2 max describes the aggregate function of the entire aerobic system.
A declining VO2 max is typically the earliest quantifiable signal that something in that system is breaking down — often years before symptoms appear.
There are three common methods for estimating VO2 max, and they are not equivalent.
The first is a submaximal prediction formula — the kind your Apple Watch or a gym-floor Fitbit produces by extrapolating from heart-rate data during daily activity. These algorithms are useful for tracking trends in recreational exercisers, but their standard error is typically in the range of ±10–15%, which is far too wide to be clinically actionable.
The second is a graded exercise test on a treadmill or bike with estimation equations (Bruce protocol, YMCA step test). This improves accuracy but still relies on population-average assumptions about mechanical efficiency that may not hold in any given patient.
The third — and the only one PURE uses in its executive health assessment Miami program — is direct measurement by cardiopulmonary exercise testing, or CPET.
In a CPET, the patient wears a medical-grade mask connected to a metabolic cart that measures, breath by breath, the volume and gas composition of every exhalation. Heart rate, 12-lead ECG, blood pressure, oxygen saturation, and respiratory exchange ratio (RER) are tracked continuously.
The test progresses through ramped intensity until the patient reaches volitional exhaustion or physiological criteria for maximal effort are met — typically an RER above 1.10 and a plateau in VO2 despite rising workload.
CPET produces not just a single VO2 max number but a rich dataset: ventilatory thresholds (VT1 and VT2, which anchor Zone 2 training prescriptions), anaerobic threshold, breathing reserve, oxygen pulse, and heart-rate recovery.
Age and sex heavily influence what constitutes a "good" VO2 max. Peter Attia, M.D., has popularized a framework based on normative data from the FRIEND registry (Fitness Registry and the Importance of Exercise National Database) that stratifies scores into percentiles by age group.
The insight executives most often find actionable: a 50-year-old man whose VO2 max sits at the 50th percentile today can, with a 5–10 year runway of disciplined Zone 2 and high-intensity interval training, realistically move into the top decile for his age — which carries a projected all-cause mortality hazard ratio roughly half that of an average-fitness peer.
Representative target ranges from the FRIEND registry (mL/kg/min):
For most of PURE's members — founders, fund managers, and family office principals living in Indian Creek, Fisher Island, and Coral Gables — the clinical conversation is rarely about whether they are "fit enough."
It is about what VO2 max decile they are on track to occupy at age 80, and what training and recovery prescription moves them up the curve most efficiently.
A VO2 max number is a starting point, not a finish line. What makes precision longevity medicine valuable is what happens after the test — specifically, how CPET data gets translated into a prescription that a busy executive can actually execute.
The modern consensus framework, popularized by exercise physiologists such as Iñigo San-Millán, Ph.D., emphasizes time in Zone 2 — the intensity corresponding to VT1, the first ventilatory threshold, where lactate begins to accumulate but is still efficiently cleared.
Zone 2 trains mitochondrial density and fat oxidation capacity, the cellular infrastructure that ultimately supports VO2 max.
Layered on top: one or two weekly high-intensity sessions (often 4x4 intervals at 90–95% of heart-rate max) that directly drive cardiac stroke volume adaptations.
Without individualized CPET data, the typical recreational athlete guesses at Zone 2 by using the "conversational pace" heuristic or a generic percentage of max heart rate. Those estimates are often wrong by 15–25 beats per minute — meaning months of training accumulate at the wrong intensity.
For an executive whose available training time is finite and precious, the CPET-anchored prescription is the difference between progress and stagnation.
A single biomarker in isolation — even one as powerful as VO2 max — will rarely change an executive's trajectory. What changes trajectories is the composite view: VO2 max read against APOE genotype, hormone optimization panel data, full body MRI findings, biological age testing epigenetic clocks, DEXA visceral fat quantification, and a detailed family history.
In PURE's executive health assessment Miami program, the VO2 max result is one of the first data points reviewed in the post-assessment consultation.
If a 52-year-old member's VO2 max returns at the 35th percentile with an APOE ε3/ε4 genotype, the clinical team prioritizes aggressive aerobic conditioning and targeted cerebrovascular risk reduction.
If the same member's VO2 max returns at the 85th percentile with an abnormal DEXA body composition, the conversation pivots to visceral adiposity and metabolic optimization.
The same test, read in different composite contexts, yields different longitudinal prescriptions.
This is the defining characteristic of luxury medicine Miami done properly: the diagnostic work is not the product. The synthesis is.
VO2 max is the maximum volume of oxygen your body can use during peak exercise, expressed in mL/kg/min. It reflects the combined capacity of your heart, lungs, vasculature, and muscle mitochondria. Large cohort studies — most notably the 2018 Cleveland Clinic analysis in JAMA Network Open — have shown that VO2 max is the single strongest predictor of all-cause mortality among commonly measured variables, with no observed upper limit of benefit.
For most members in PURE's longevity program, annual VO2 max testing is appropriate — frequent enough to confirm that training prescriptions are working and infrequent enough to capture meaningful change. Members enrolled in intensive intervention periods (post-injury return to training, new medication trials, aggressive body composition programs) may benefit from semi-annual testing.
Formal CPET is extensively validated in adults of all ages and is routinely performed in cardiology and pulmonary practice. At PURE, every CPET is physician-supervised with continuous 12-lead ECG and blood-pressure monitoring, and the test is individualized to each patient's medical history. Patients with known significant cardiovascular disease may require modified protocols, which are determined during pre-test screening.
Genetics account for roughly 50% of an individual's VO2 max ceiling, but the remaining trainable component is substantial. Most previously sedentary adults can improve VO2 max by 15–25% within six months of structured training combining Zone 2 volume with high-intensity intervals. The trainable component persists into the eighth and ninth decades of life, though the rate of improvement slows with age.
A standard cardiac stress test is designed to detect ischemia — inadequate blood flow to the heart muscle during exertion — and typically stops when diagnostic information has been obtained. A full CPET with VO2 max measurement is designed to characterize maximal aerobic capacity and produces a substantially richer dataset, including ventilatory thresholds, gas exchange, and oxygen pulse. The two tests have different goals and are not interchangeable.
No. The most useful time to measure VO2 max is before starting a training program — the initial test establishes your baseline, identifies your personal heart-rate zones, and anchors every measurement that follows. Training to "look good" before the test defeats its diagnostic purpose.
PURE's facility is purpose-built for single-visit executive health assessments — full CPET, labs, imaging, and physician consultation are typically completed in a half-day window.